ARK Investment Management LLC 13D and 13G filings for Arcturus Therapeutics Holdings Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-29 4:01 pm Purchase |
2023-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT |
ARK Investment Management LLC | 2,047,687 7.660% |
35,258 (+1.75%) |
Filing |
| 2023-02-10 10:48 am Sale |
2022-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT |
ARK Investment Management LLC | 2,012,429 7.580% |
-460,201 (-18.61%) |
Filing |
| 2022-02-09 2:03 pm Sale |
2021-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT |
ARK Investment Management LLC | 2,472,630 9.380% |
-380,628 (-13.34%) |
Filing |
| 2021-11-09 12:03 pm Sale |
2021-10-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT |
ARK Investment Management LLC | 2,853,258 10.840% |
-1,105,761 (-27.93%) |
Filing |
| 2021-02-16 4:33 pm Purchase |
2020-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT |
ARK Investment Management LLC | 3,959,019 15.310% |
1,463,177 (+58.62%) |
Filing |
| 2020-10-09 1:41 pm Purchase |
2020-03-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT |
ARK Investment Management LLC | 2,495,842 10.230% |
2,495,842 (New Position) |
Filing |